# Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury

> **NCT02794168** · PHASE3 · COMPLETED · sponsor: **veriNOS operations GmbH** · enrollment: 224 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** VAS203
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02794168
- **Lead sponsor:** veriNOS operations GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2021-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794168, "Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02794168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*